Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reducing Cannabis Use for Sleep Among Adults Using Medical Cannabis (CannSleep)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03964974
Recruitment Status : Recruiting
First Posted : May 28, 2019
Last Update Posted : April 21, 2020
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Mark A. Ilgen, University of Michigan

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021
Publications:
Substance Abuse and Mental Health Services Administration. Results from the 2009 National Survey on Drug Use and Health: National findings. Vol HHS Publication No. SMA 10-4856Findings. Rockville, MD.: Office of Applied Studies; 2010.
Substance A, Mental Health Services Administration CfBHS, Quality. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: United States Department of Health and Human Services, Substance Abuse and Mental Health Services Administration;2014.
Gillin J, Kotin J, Post R. Sleep during one week of administration of Δ-9 tetrahydrocanabinol to psychiatric patients. J Sleep Res. 1972;1:44.
Association AP. Diagnostic and Statistical Manual of Mental Disorders (DSM-5®): American Psychiatric Pub; 2013.
Morin CM. Insomnia: Psychological assessment and management. New York: The Guilford Press; 1993.
Bootzin RR, Nicassio PM. Behavioral treatments for insomnia. In: Hersen M, Eissler R, Miller P, eds. Progress in Behavior Modification. Vol 6. New York, NY: Academic Press; 1978:1-45.
Fellman-Couture C, Pillai V, Arnedt JT, et al. Long-term Efficacy of Cognitive Behavior Therapy for Menopausal Insomnia. Sleep. Denver, CO2016.
Perlis M, Jungquist C, Smith M, Posner D. Cognitive behavioral therapy for insomnia: a session-by-session guide: Springer, New York; 2005.
Iber C, Ancoli-Israel S, Chesson A, Quan SFftAAoSM. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, 1st ed. Westchester, Illinois: American Academy of Sleep Medicine; 2007.
Berry RB, R. Brooks, C. E. Gamaldo, et al. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, Version 2.1. Darien, IL, : American Academy of Sleep Medicine; 2014.
Jasper HH. The ten twenty electrode system of the international federation. Electroencephalography and clinical neurophysiology. 1958;10:371-375.
Smith GE, Ross RL, Rost KM. Psychiatric outcomes module: substance abuse outcomes module (SAOM). In: Sederer LI, Dickey B, eds. Outcome assessment in clinical practice. Baltimore, MD: Williams and Wilkins; 1996:85-88.
Lacks P. Behavioral Treatment for Persistent Insomnia. New York, NY: Pergamon Press; 1987.
Fichten CS, Libman E, Creti L, et al. Role of thoughts during nocturnal awake times in the insomnia experience of older adults. Cognitive Therapy and Research. 2001;25(6):665-692.
Simons J, Correia CJ, Carey KB, Borsari BE. Validating a five-factor marijuana motives measure: Relations with use, problems, and alcohol motives. Journal of Counseling Psychology. 1998;45(3):265.
Sobell LC, Sobell MB. Timeline follow-back. Measuring alcohol consumption: Springer; 1992:41-72.
Little RJ, Rubin DB. Statistical analysis with missing data. New York: Wiley & Sons; 1987.